These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29145931)

  • 1. In vitro and in silico Approaches to Study Cytochrome P450-Mediated Interactions.
    Tan BH; Pan Y; Dong AN; Ong CE
    J Pharm Pharm Sci; 2017; 20(1):319-328. PubMed ID: 29145931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug metabolism and drug interactions: application and clinical value of in vitro models.
    Venkatakrishnan K; von Moltke LL; Obach RS; Greenblatt DJ
    Curr Drug Metab; 2003 Oct; 4(5):423-59. PubMed ID: 14529374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of cytochrome P450 drug interaction screening in drug discovery.
    Foti RS; Wienkers LC; Wahlstrom JL
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):145-58. PubMed ID: 20053168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico prediction of cytochrome P450-mediated drug metabolism.
    Zhang T; Chen Q; Li L; Liu LA; Wei DQ
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):388-95. PubMed ID: 21470181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro approaches to investigate cytochrome P450 activities: update on current status and their applicability.
    Ong CE; Pan Y; Mak JW; Ismail R
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1097-113. PubMed ID: 23682848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the CEIBA Cocktail Designed for Human Cytochrome P450 Enzymes be Used in the Rat for Drug Interaction Studies?
    Magalhães P; De Andrés F; Falcão A; LLerena A; Alves G
    J Pharm Pharm Sci; 2016; 19(4):520-529. PubMed ID: 28057170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application and development of in vitro metabolism study at early drug discovery stage].
    Wu H; Peng Y; Sun JG; Zhang XY; Zhong YX; Wang GJ
    Yao Xue Xue Bao; 2013 Jul; 48(7):1071-9. PubMed ID: 24133972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity.
    Carosati E
    Drug Discov Today Technol; 2013; 10(1):e167-75. PubMed ID: 24050246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions.
    Baneyx G; Fukushima Y; Parrott N
    Future Med Chem; 2012 Apr; 4(5):681-93. PubMed ID: 22458685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico prediction of drug metabolism by P450.
    Andrade CH; Silva DC; Braga RC
    Curr Drug Metab; 2014; 15(5):514-25. PubMed ID: 25204822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.
    Tyzack JD; Kirchmair J
    Chem Biol Drug Des; 2019 Apr; 93(4):377-386. PubMed ID: 30471192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction phenotyping to assess victim drug-drug interaction risks.
    Di L
    Expert Opin Drug Discov; 2017 Nov; 12(11):1105-1115. PubMed ID: 28820269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and development.
    Callegari E; Kalgutkar AS; Leung L; Obach RS; Plowchalk DR; Tse S
    Drug Metab Dispos; 2013 Dec; 41(12):2047-55. PubMed ID: 23792812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Drugs on oxygen": an update and perspective on the role of cytochrome P450 testing in pharmacology.
    Tralau T; Luch A
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1357-62. PubMed ID: 22970688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism.
    Ansede JH; Thakker DR
    J Pharm Sci; 2004 Feb; 93(2):239-55. PubMed ID: 14705182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes.
    Zientek MA; Youdim K
    Drug Metab Dispos; 2015 Jan; 43(1):163-81. PubMed ID: 25297949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes.
    Mikov M; Đanić M; Pavlović N; Stanimirov B; Goločorbin-Kon S; Stankov K; Al-Salami H
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):881-890. PubMed ID: 28534261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico site of metabolism prediction of cytochrome P450-mediated biotransformations.
    Tarcsay Á; Keseru GM
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):299-312. PubMed ID: 21291341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of predictive metabolism and toxicity modeling in drug discovery--a summary of some recent advancements.
    Wilson AG; White AC; Mueller RA
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):123-8. PubMed ID: 12613284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of in silico contributions to drug metabolism in lead optimization.
    Vaz RJ; Zamora I; Li Y; Reiling S; Shen J; Cruciani G
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):851-61. PubMed ID: 20565339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.